Valneva outlines $145M-$160M 2026 revenue guidance while Pfizer targets Lyme decisions within 12 months
Valneva outlines $145M-$160M 2026 revenue guidance while Pfizer targets Lyme decisions within 12 months. Destaque: $145, $160.
Notícias
Acompanhe as Notícias da Recifes
Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.
SBC targets 1,000 clinics by 2035 while outlining $15M annual fee upside
SBC targets 1,000 clinics by 2035 while outlining $15M annual fee upside. Destaque: $15.
SolarEdge options trade targets a rally to $50 by December 2026
Repercussão envolvendo fonte internacional chama atenção em Economia. Destaque: $50.
Sandisk’s stock is flying higher. Here are the new targets that are exciting Wall Street.
Repercussão envolvendo Wall Street chama atenção em Carreira.
A new ADHD drug targets three brain chemicals instead of two. Here's what that means
Repercussão envolvendo fonte internacional chama atenção em Fitness.
Okta targets AI agent token costs with MCP scoping
Okta says identity-scoped Model Context Protocol (MCP) tool lists can reduce AI agent token costs. Destaque: 90%.
Amdocs at Oppenheimer conference: ai push targets telecom reinvention
Amdocs at Oppenheimer conference: ai push targets telecom reinvention.
Arq outlines $120M-$125M 2026 revenue and targets up to 50% adjusted EBITDA increase as PAC for PFAS advances
Arq outlines $120M-$125M 2026 revenue and targets up to 50% adjusted EBITDA increase as PAC for PFAS advances. Destaque: 50%, $120, $125.
Refreshed Rory returns for FedExCup Playoffs as he targets fourth title
Rory McIlroy returns to action at the FedEx St. Jude Championship this week, live on Sky Sports, with the world No 2 targeting a big finish to the PGA Tour season and a record-extending fourth FedExCup title.
RadNet targets over $140M of Digital Health ARR by end of 2026 as it raises imaging center
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Finanças.
Study suggests experimental drug dismantles 2 key proteins that help tumors survive, adapt
Scientists from Roswell Park Comprehensive Cancer Center report that the investigational anticancer agent FL118 functions as a dual molecular glue degrader that directly targets and degrades the proteins DDX5 and UbE2T, two emerging therapeutic targets linked to cancer survival m
Ukrainian drone attack kills at least 13 in central Russia
Ukraine launched hundreds of drones at targets inside Russia, according to Russian officials. The strikes killed more than a dozen in one of Kyiv's deadliest attacks since the Russian invasion began over four years ago.